Literature DB >> 31785745

Ultrasound Assessment of the Superior Capsular Reconstruction With Dermal Allograft: An Evaluation of Graft Thickness and Vascularity.

Alan M Hirahara1, Wyatt J Andersen2, Alberto J Panero2.   

Abstract

PURPOSE: To assess postoperative changes in the thickness of the dermal allograft of the superior capsular reconstruction (SCR) and to evaluate the graft for the presence of intrasubstance pulsatile vessels.
METHODS: A retrospective chart review was conducted to identify SCR patients who had ultrasound evaluations between May 2014 and February 2019. Data were collected and stratified based on time from surgery into 2 groups: 0 to 12 months and past the 12-month follow-up. The primary outcome measure was graft thickness at the articular margin-greater tuberosity interface (tuberosity measurement). Secondary measures included midsubstance graft thicknesses 0.5, 1.0, and 1.5 cm medial to the tuberosity measurement; status of lateral graft fixation; presence of pulsatile vessels; and American Shoulder and Elbow Society and visual analog scale scores.
RESULTS: Eighteen patients were included for analysis. The tuberosity measurement at final follow-up (mean 25 months, range 12-40 months) was (mean ± standard error [95% confidence interval (CI)]) 4.4 ± 0.2 mm (95% CI 4.0-4.8). This differed significantly from the midsubstance measurements: 0.5 cm: 3.6 ± 0.2 mm (95% CI 3.3-4.0, P = .008); 1.0 cm: 3.1 ± 0.2 mm (95% CI 2.7-3.4, P < .001); and 1.5 cm: 2.9 ± 0.2 mm (95% CI 2.6-3.2, P < .001). Ten constructs (56%) showed signs of pulsatile vessels in the first 12 months and all constructs were intact. ASES scores improved from 49.3 ± 4.0 (95% CI 41.6-57.1) preoperatively to 85.1 ± 2.9 (95% CI 79.4-90.8) (P < .001), and VAS scores decreased from 5.3 ± 0.6 (95% CI 4.2-6.5) preoperatively to 0.9 ± 0.3 (95% CI 0.3-1.5) at final follow-up (P < .001).
CONCLUSIONS: The SCR dermal allograft significantly thickens at its lateral aspect, presents with evidence of vasculature in most patients in the first year of implantation, and is not resorbed by the body. LEVEL OF EVIDENCE: Level IV - therapeutic case series.
Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31785745     DOI: 10.1016/j.arthro.2019.06.042

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  3 in total

1.  Which Factors Influence Clinical Outcomes After Superior Capsular Reconstruction Surgery?

Authors:  Seung-Jun Lee; Suk-Woong Kang; Ilkwon Chung; Hyungseo Jang
Journal:  Orthop J Sports Med       Date:  2020-12-16

Review 2.  Clinical outcomes of latissimus dorsi tendon transfer and superior capsular reconstruction for irreparable rotator cuff tears: a systematic review.

Authors:  Samuel E Broida; Aidan P Sweeney; Michael B Gottschalk; Jarret M Woodmass; Eric R Wagner
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-08-09

Review 3.  Clinical Outcomes of Superior Capsular Reconstruction for Massive, Irreparable Rotator Cuff Tears: A Systematic Review Comparing Acellular Dermal Allograft and Autograft Fascia Lata.

Authors:  Tyler J Smith; Anirudh K Gowd; John Kunkel; Lisa Kaplin; John B Hubbard; Kevin E Coates; Benjamin R Graves; Brian R Waterman
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.